HONG KONG, LONDON] Ever since AstraZeneca shocked investors in October with news its China chief was under investigation, the ...

Sinopharm is transforming into a one-stop distribution service provider by offering more value-added services along the distribution chain. For instance, it provides inventory management services for ...

However, for the Company, 2024 was both a “year of restructuring” amidst challenges and a “year of breakthroughs” with emerging potentials. Although the overall performance is experiencing short-term ...

BEIJING] AstraZeneca will invest US$2.5 billion in a new research centre in Beijing, in a major show of commitment to China ...

Eli Lilly, Adaptimmune, Aurion Biotech, and ImmunityBio had breakthrough medicines and therapies debut in the past year.

Klick Health is kicking up its expansion in the Asia-Pacific region. | Klick Health is kicking up its expansion in the ...

Although Klick Health declined to divulge their client list or staffing levels, the deal has seen all of Ward6’s Singapore ...

Brazil's health regulators have approved Telix Pharmaceuticals' nuclear imaging agent for prostate cancer, Illucix.

Tata Communications, Signature Global, Power Grid, GR Infraprojects, Welspun Specialty, and Kolte Patil are among the top ...

However, Singapore is vulnerable to a potential 25% US tariff on pharmaceuticals. Singapore’s tariffs on US goods—and vice ...

Unlike other companies, OpenAI does not struggle with market demand ... Speaking about the rapid uptick in ChatGPT usage at ...